👁 Anthropic is quietly building a biological AI machine

Anthropic is no longer limiting itself to software. The company has quietly set up a biology lab in the San Francisco Bay Area as it expands into drug discovery, Reuters reported.

The move comes as governments and researchers increasingly debate the risks of giving powerful AI systems access to biological tools and laboratory processes.

♦️ Anthropic is developing systems that can connect AI models with lab equipment to automate parts of biological research

♦️ The company launched Claude Science, acquired biotech startup Coefficient Bio in a $400 million stock deal, and added Novartis CEO Vas Narasimhan to its board

The promise is faster scientific discovery. The concern is that the same capabilities that help design medicines could also lower barriers to dangerous biological experimentation if they are not properly controlled.

👍 Substack | Chat | @geopolitics_prime